Prostate Cancer

Satraplatin's approval review deadline gets pushed back by the FDA and a large clinical trial shows Vidaza extends survival in patients with MDS.

Why wasn’t Provenge approved?

Minimally invasive technologies transform the landscape of cancer surgery.

The FDA approves third kidney cancer drug and blood-clotting therapy while delaying review on a prostate cancer vaccine, and one drug edges another in a colorectal cancer clinical trial.

Causes of erectile dysfunction can vary, while treatment options abound.

An approval in breast cancer, positive clinical trial results in liver cancer, while a prostate cancer drug disappoints.

Arnold Palmer's campaign to affect cancer on the front end takes him beyond the green.

The goal of screening for prostate cancer is to find cancer early, before it starts to cause symptoms, in the hope that it can be treated more effectively.

Chemoprevention options exist for individuals with high risk of breast, prostate, or colorectal cancers.